معرفی
Sanne Schuite-Koops is an academic researcher with expertise in psychiatry, neuroscience, and neuropharmacology, focusing on first-episode psychosis, antipsychotic medication management, and hallucination treatment. She collaborates extensively within the HAMLETT OPHELIA Consortium and TAPER international research consortium, contributing to global mental health research aligned with UN Sustainable Development Goals.
Her research addresses critical challenges in psychotic disorders, including:
- Psychopharmacological mechanisms of antipsychotics (D2 receptor affinity)
- Neurostimulation techniques for hallucinations (rTMS, tDCS)
- Evidence-based tapering strategies for antipsychotic medication
- Ecological momentary assessment of social functioning post-remission
Recent publications highlight her work on relapse risk prediction, negative symptom management, and international clinical guidelines. She actively supervises research and bridges gaps between clinical studies and real-world mental healthcare implementation.
Her affiliations span multidisciplinary collaborations across institutions, with research outputs accessible via open-access platforms. While specific institutional ties remain unlisted in the provided text, her work impacts schizophrenia research, psychotic recovery models, and innovative treatment protocols.
